First UK clinical guidelines for Tuberous Sclerosis Complex will drive higher quality and more consistent care from the NHS

First UK clinical guidelines for Tuberous Sclerosis Complex will drive higher quality and more consistent care from the NHS The Tuberous Sclerosis Association (TSA) is delighted to announce the publication of the first UK clinical guidelines for the management and surveillance of Tuberous Sclerosis Complex

NHS England announce that everolimus is to be funded for TSC-related refractory epilepsy from April 2019

The TSA is delighted to announce that NHS England has backed recommendations from the Clinical Priorities Advisory Group to fund everolimus for the treatment of refractory epilepsy in people with Tuberous Sclerosis Complex (TSC) in England. Everolimus will be funded from April 2019. NHS England’s

Goodbye and thank you Sue

It was with great sadness that we brought you news earlier this month that Professor Sue Povey, a pioneer in the field of genetics and TSC, had passed away. Here Professor Julian Sampson (Director, Division of Cancer and Genetics, Cardiff University and Professor Sue Povey’s